Skip to main content
. 2019 Jul 19;9:10506. doi: 10.1038/s41598-019-46848-8

Figure 1.

Figure 1

Treatment with a high-dose GSK3β inhibitor predominantly induced posterior DE. (A) A schematic diagram of posterior DE induction using Activin A and CHIR99021. (B) An expression analysis of SOX17 and CDX2 in differentiated cells treated with the indicated dose of CHIR by qPCR (n = 3 independent experiments; mean ± SEM). (C) Immunostaining of SOX17 and CDX2 in differentiated cells. Representative fluorescence microscopic images for treatment with 1 µM (upper panels) and 5 µM CHIR (lower panels) are shown. Scale bar, 50 μm. (D) The proportion of CDX2-positive cells after treatment with 1 or 5 µM CHIR (n = 3 independent experiments; mean ± SD). *p < 0.05; two-tailed paired t-test. Abbreviations: iPSc, induced pluripotent stem cell; DE, definitive endoderm; CHIR, CHIR99021.